SEC Stock Data Quick Answer XWELL, Inc. reported Total Revenue of $33.90 million for fiscal year 2024. XWELL, Inc. Total Revenue — Annual History Fiscal Year Total Revenue YoY Change 2024 $33.90M +12.6% 2023 $30.11M -46.2% 2022 $55.94M -24.1% 2021 $73.73M +779.3% 2020 $8.38M -82.7% 2019 $48.52M -3.2% 2018 $50.09M +2.6% 2017 $48.82M +307.3% 2016 $11.99M -47.2% 2015 … Read more
Quick Answer XWELL, Inc. reported Total Revenue of $33.90 million for fiscal year 2024. XWELL, Inc. — Key Financials by Year Metric 2024 2023 2022 2021 2020 2019 Total Revenue $33.90M+12.6% $30.11M-46.2% $55.94M-24.1% $73.73M+779.3% $8.38M-82.7% $48.52M-3.2% Revenue (ASC 606) $33.90M+12.6% $30.11M-46.2% $55.94M-24.1% $73.73M+779.3% $8.38M-82.7% $48.52M Net Income -$16.85M+39.2% -$27.74M+15.5% -$32.84M-1080.5% $3.35M+103.7% -$90.49M-326.4% -$21.22M+43.0% Diluted EPS … Read more
Quick Answer Adastra Holdings Ltd. reported Gross Profit of $6.11 million for fiscal year 2022. Adastra Holdings Ltd. Gross Profit — Annual History Fiscal Year Gross Profit YoY Change 2022 $6.11M +214.5% 2021 $1.94M +147.4% 2020 $785.6K — Adastra Holdings Ltd. showed an increase of +214.5% in Gross Profit compared to the prior fiscal year. … Read more
Quick Answer Adastra Holdings Ltd. reported R&D Expense of $0.00 for fiscal year 2022. Adastra Holdings Ltd. R&D Expense — Annual History Fiscal Year R&D Expense YoY Change 2022 $0.00 -100.0% 2021 $89.3K -50.9% 2020 $181.8K — Adastra Holdings Ltd. showed a decrease of -100.0% in R&D Expense compared to the prior fiscal year. Over … Read more
Quick Answer Adastra Holdings Ltd. reported Total Assets of $31.80 million for fiscal year 2022. Adastra Holdings Ltd. Total Assets — Annual History Fiscal Year Total Assets YoY Change 2022 $31.80M +10.6% 2021 $28.76M +109.3% 2020 $13.74M — Adastra Holdings Ltd. showed an increase of +10.6% in Total Assets compared to the prior fiscal year. … Read more
Quick Answer Adastra Holdings Ltd. reported Total Assets of $31.80 million for fiscal year 2022. Adastra Holdings Ltd. — Key Financials by Year Metric 2022 2021 2020 Total Assets $31.80M+10.6% $28.76M+109.3% $13.74M R&D Expense $0.00-100.0% $89.3K-50.9% $181.8K Gross Profit $6.11M+214.5% $1.94M+147.4% $785.6K Adastra Holdings Ltd. reported Total Assets of $31.80 million for fiscal year 2022. … Read more
Quick Answer Xtant Medical Holdings, Inc. reported Shares Outstanding of 140.04 million shares for fiscal year 2025. Xtant Medical Holdings, Inc. Shares Outstanding — Annual History Fiscal Year Shares Outstanding YoY Change 2025 140.04M +0.7% 2024 139.05M +6.8% 2023 130.18M +19.6% 2022 108.87M +25.0% 2021 87.07M +12.2% 2020 77.57M +489.4% 2019 13.16M -0.1% 2018 13.17M … Read more
Quick Answer Xtant Medical Holdings, Inc. reported Gross Profit of $84.27 million for fiscal year 2025. Xtant Medical Holdings, Inc. Gross Profit — Annual History Fiscal Year Gross Profit YoY Change 2025 $84.27M +23.5% 2024 $68.22M +23.0% 2023 $55.47M +72.6% 2022 $32.14M -1.1% 2021 $32.49M -5.5% 2020 $34.39M -19.1% 2019 $42.52M -2.2% 2018 $43.49M -13.2% … Read more
Quick Answer Xtant Medical Holdings, Inc. reported Operating Income of $7.28 million for fiscal year 2025. Xtant Medical Holdings, Inc. Operating Income — Annual History Fiscal Year Operating Income YoY Change 2025 $7.28M +160.3% 2024 -$12.07M -18.9% 2023 -$10.16M -50.4% 2022 -$6.75M -75.3% 2021 -$3.85M -413.2% 2020 -$751.0K +66.7% 2019 -$2.25M +96.2% 2018 -$60.08M -58.8% … Read more
Quick Answer Xtant Medical Holdings, Inc. reported R&D Expense of $2.10 million for fiscal year 2025. Xtant Medical Holdings, Inc. R&D Expense — Annual History Fiscal Year R&D Expense YoY Change 2025 $2.10M -11.9% 2024 $2.38M +78.5% 2023 $1.34M +46.0% 2022 $915.0K +5.2% 2021 $870.0K +32.4% 2020 $657.0K -29.5% 2019 $932.0K -45.2% 2018 $1.70M -30.3% … Read more